Anika Therapeutics, Inc. Logo

Anika Therapeutics, Inc.

A global joint preservation company developing solutions for orthopedic care.

ANIK | US

Overview

Corporate Details

ISIN(s):
US0352551081
LEI:
Country:
United States of America
Address:
32 WIGGINS AVENUE, 1730 BEDFORD

Description

Anika Therapeutics, Inc. is a global joint preservation company focused on developing, manufacturing, and marketing solutions for early intervention orthopedic care. The company provides a range of therapeutic products and regenerative solutions designed to treat degenerative orthopedic diseases, traumatic conditions, joint pain, and arthritis. Its portfolio, which utilizes technologies such as hyaluronic acid, aims to restore joint function and enable patients to maintain an active lifestyle. Key products include the Integrity™ Implant System, a regenerative scaffold for tendon augmentation. Anika partners with medical professionals to deliver treatments across the continuum of joint care.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-21 10:21 English 10.0 KB
2025-11-07 07:06 English 11.7 KB
2025-11-05 17:01
FORM S-8
English 66.7 KB
2025-11-05 17:01
FORM 10-Q
English 1.1 MB
2025-11-05 08:20
FORM 8-K
English 132.8 KB
2025-10-17 14:45 English 12.5 KB
2025-07-30 18:12
FORM 10-Q
English 1.1 MB
2025-07-30 09:21
FORM 8-K
English 117.4 KB
2025-07-30 09:15
FORM 8-K
English 83.7 KB
2025-07-24 10:36 English 57.2 KB
2025-07-17 18:28 English 22.5 KB
2025-06-24 19:14 English 7.1 KB
2025-06-24 19:13 English 7.0 KB
2025-06-24 19:13 English 6.9 KB
2025-06-24 19:12 English 7.4 KB

Automate Your Workflow. Get a real-time feed of all Anika Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Anika Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Anika Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Advicenne Logo
A specialty pharmaceutical company developing treatments for rare renal diseases.
France
ALDVI
AegirBio AB Logo
A diagnostics company specializing in therapeutic drug monitoring for biological drugs.
Sweden
AEGIR
Aelis Farma Logo
Biopharmaceutical company developing CB1 receptor inhibitors for CNS disorders.
France
AELIS
AEON Biopharma, Inc. Logo
Clinical-stage company developing therapeutic applications for botulinum toxins.
United States of America
AEON
AFC-HD AMS Life Science Co.,Ltd. Logo
An OEM of health foods, supplements, and cosmetics with integrated R&D and manufacturing.
Japan
2927
AGENUS INC Logo
A clinical-stage biotechnology company specializing in immuno-oncology therapies.
United States of America
AGEN
AGIOS PHARMACEUTICALS, INC. Logo
Biopharmaceutical company developing therapies for rare and genetically defined diseases.
United States of America
AGIO
AHN-GOOK PHARMACEUTICAL Co., Ltd. Logo
Develops and markets medicines, focusing on respiratory and cardiovascular treatments.
South Korea
001540
Akari Therapeutics Plc Logo
Develops next-gen antibody-drug conjugates using proprietary cancer-killing toxins.
United States of America
AKTX
Akebia Therapeutics, Inc. Logo
A biopharmaceutical company that develops and commercializes therapeutics for kidney disease.
United States of America
AKBA

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.